In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 2, 1997, Pages 205-211

  Cohen, Michael A ^a   Huband, Michael D ^a   Gage, Jeffrey W ^a   Yoder, Steven L ^a   Roland, Gregory E ^a   Gracheck, Stephen J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINAFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; QUINOLONES;

EID: 0030867475     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.2.205     Document Type: Article

References (6)

1. Barry, A. L., Fuchs, P. C. & Brown, S. D. (1996). In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents. Antimicrobial Agents and Chemotherapy 40, 2431-3.
2. Visalli, M. A., Jacobs, M. R. & Applebaum, P. C. (1996). Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology. Journal of Antimicrobial Chemotherapy 37, 77-84.
3. Cormican, M. G. & Jones, R. N. (1996). In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates. Journal of Antimicrobial Chemotherapy 37, 847-9.
4. Cohen, M. A., Huband, M. D., Mailloux, G. B., Yoder, S. L., Roland, G. E. & Heifetz, C. L. (1991). In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagnostic Microbiology and Infectious Disease 14, 245-58.
5. Barry, A. L., Brown, S. D. & Fuchs, P. C. (1996). In-vitro selection of quinolone-resistant staphylococcal mutants by a single exposure to ciprofloxacin or trovafloxacin (CP-99,219). Journal of Antimicrobial Chemotherapy 38, 324-7.
6. Scheel, O., Lyon, D. J., Rosdahl, V. T., Adeyemi-Doro, F. A. B., Ling, T. K. W. & Cheng, A. F. B. (1996). In-vitro susceptibility of isolates of methicillin-resistant Staphylococcus aureus 1988-1993. Journal of Antimicrobial Chemotherapy 37, 243-51.